Zero Tolerance For Counterfeit Medicines

Counterfeit medicines, already widespread in the developing world, are now being found increasingly in the EU. While Internet-based sales are the main source of counterfeit medicines, these products are also appearing in the traditional supply chain. Urgent measures are required to protect European patients, including a ban on medicine repackaging. "Even one single case of counterfeit medicine is unacceptable", commented Brian Ager, Director General of EFPIA.

http://www.medicalnewstoday.com/articles/107226.php